Natus Medical Incorporated (BABY) Shares Sold by Principal Financial Group Inc.

Principal Financial Group Inc. lowered its stake in Natus Medical Incorporated (NASDAQ:BABY) by 0.7% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 250,798 shares of the medical equipment provider’s stock after selling 1,698 shares during the quarter. Principal Financial Group Inc. owned 0.77% of Natus Medical worth $9,405,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the company. Benjamin F. Edwards & Company Inc. increased its stake in Natus Medical by 2,085.6% during the 3rd quarter. Benjamin F. Edwards & Company Inc. now owns 2,732 shares of the medical equipment provider’s stock valued at $102,000 after purchasing an additional 2,607 shares in the last quarter. Riverhead Capital Management LLC increased its stake in Natus Medical by 90.9% during the 2nd quarter. Riverhead Capital Management LLC now owns 2,864 shares of the medical equipment provider’s stock valued at $107,000 after purchasing an additional 1,364 shares in the last quarter. Sei Investments Co. increased its stake in Natus Medical by 29.7% during the 2nd quarter. Sei Investments Co. now owns 3,182 shares of the medical equipment provider’s stock valued at $119,000 after purchasing an additional 728 shares in the last quarter. Victory Capital Management Inc. increased its stake in Natus Medical by 17.6% during the 2nd quarter. Victory Capital Management Inc. now owns 3,744 shares of the medical equipment provider’s stock valued at $140,000 after purchasing an additional 560 shares in the last quarter. Finally, Flinton Capital Management LLC increased its stake in Natus Medical by 82.0% during the 2nd quarter. Flinton Capital Management LLC now owns 3,774 shares of the medical equipment provider’s stock valued at $141,000 after purchasing an additional 1,700 shares in the last quarter. Institutional investors own 94.39% of the company’s stock.

Shares of Natus Medical Incorporated (NASDAQ BABY) opened at $38.75 on Tuesday. The company has a market cap of $1,210.00, a price-to-earnings ratio of 25.42 and a beta of 0.84. The company has a debt-to-equity ratio of 0.36, a quick ratio of 3.36 and a current ratio of 4.21. Natus Medical Incorporated has a one year low of $31.65 and a one year high of $43.60.

Natus Medical (NASDAQ:BABY) last announced its quarterly earnings results on Wednesday, October 25th. The medical equipment provider reported $0.40 EPS for the quarter, beating the Zacks’ consensus estimate of $0.38 by $0.02. The business had revenue of $122.60 million during the quarter, compared to analyst estimates of $122.41 million. Natus Medical had a negative net margin of 0.62% and a positive return on equity of 12.06%. Natus Medical’s quarterly revenue was up 34.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.39 EPS. equities research analysts forecast that Natus Medical Incorporated will post 1.74 earnings per share for the current fiscal year.

A number of analysts have commented on BABY shares. BidaskClub lowered shares of Natus Medical from a “sell” rating to a “strong sell” rating in a research note on Thursday, August 24th. Zacks Investment Research upgraded shares of Natus Medical from a “sell” rating to a “hold” rating in a research note on Friday, September 22nd. Two analysts have rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $46.50.

In other Natus Medical news, Director William M. Moore sold 5,000 shares of Natus Medical stock in a transaction on Monday, November 13th. The shares were sold at an average price of $41.01, for a total transaction of $205,050.00. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, VP Dong Chune Christopher Chung sold 12,642 shares of Natus Medical stock in a transaction on Monday, November 6th. The stock was sold at an average price of $42.91, for a total transaction of $542,468.22. Following the transaction, the vice president now directly owns 141,414 shares in the company, valued at $6,068,074.74. The disclosure for this sale can be found here. Insiders have sold a total of 22,042 shares of company stock worth $902,266 over the last ninety days. Insiders own 5.50% of the company’s stock.

WARNING: This piece was posted by Community Financial News and is the property of of Community Financial News. If you are viewing this piece on another site, it was copied illegally and republished in violation of U.S. & international copyright law. The correct version of this piece can be viewed at https://www.com-unik.info/2017/12/05/natus-medical-incorporated-baby-shares-sold-by-principal-financial-group-inc.html.

Natus Medical Company Profile

Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.

Want to see what other hedge funds are holding BABY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Natus Medical Incorporated (NASDAQ:BABY).

Institutional Ownership by Quarter for Natus Medical (NASDAQ:BABY)

What are top analysts saying about Natus Medical Incorporated? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Natus Medical Incorporated and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit